Lexagene Holdings (Lexagene Holdings) COGS-to-Revenue : 4.42 (As of Nov. 2022)

View and export this data going back to 2017. Start your Free Trial

What is Lexagene Holdings COGS-to-Revenue?

Lexagene Holdings's Cost of Goods Sold for the three months ended in Nov. 2022 was $0.19 Mil. Its Revenue for the three months ended in Nov. 2022 was $0.04 Mil.

Lexagene Holdings's COGS to Revenue for the three months ended in Nov. 2022 was 4.42.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Lexagene Holdings's Gross Margin % for the three months ended in Nov. 2022 was -341.86%.

Lexagene Holdings COGS-to-Revenue Historical Data

The historical data trend for Lexagene Holdings's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lexagene Holdings COGS-to-Revenue Chart

Lexagene Holdings Annual Data

Trend

Mar13

Mar14

Mar15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

COGS-to-Revenue

Get a 7-Day Free Trial

2.74

7.24

Lexagene Holdings Quarterly Data
	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22
COGS-to-Revenue	Get a 7-Day Free Trial															3.08	-	10.40	4.07	4.42

Lexagene Holdings COGS-to-Revenue Calculation

Lexagene Holdings's COGS to Revenue for the fiscal year that ended in Feb. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.543	/	0.075
	=	7.24

Lexagene Holdings's COGS to Revenue for the quarter that ended in Nov. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.19	/	0.043
	=	4.42

Lexagene Holdings (OTCPK:LXXGQ) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Lexagene Holdings's Gross Margin % for the three months ended in Nov. 2022 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0.19 / 0.043
	=	-341.86 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Lexagene Holdings COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Lexagene Holdings's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Lexagene Holdings (Lexagene Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lexagene Holdings Inc (OTCPK:LXXGQ) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

500 Cummings Center, Suite 4550, Beverly, MA, USA, 01915

Website

https://www.lexagene.com

Lexagene Holdings Inc is a molecular diagnostics company that develops molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The MiQLab system delivers sensitivity, specificity, and breadth of detection and can return results in approximately two hours. The unique open-access feature is designed for custom testing so that end-users can load their own real-time PCR assays onto the instrument to target any genetic target of interest.